ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Klyx® Magnum:Ferring AG
Vollst. FachinformationDDDDrucken 
Gal.Form/Ther.Gr.Zusammens.Eigensch.Pharm.kinetikInd./Anw.mögl.Dos./Anw.Anw.einschr.Unerw.Wirkungen
Interakt.Sonstige H.Swissmedic-Nr.Stand d. Info. 
A06AG10 - Docusate Sodium, incl. CombinationsATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A06 - Drugs for Constipation
 
A06A - Drugs for Constipation

All agents used for treatment of constipation (regardless of indication) are classified here.
The agents are mainly subdivided according to mode of action. All enemas are classified in A06AG, regardless of mode of action.
Some combination products are classified at separate levels. These are mentioned in the respective ATC group.
Otherwise combination products are classified at separate 5th levels using the corresponding 50-series.
Laxatives in combination with centrally acting antiobesity agents are classified in A08A - Antiobesity preparations, excl. diet products.

A06AG - Enemas

All enemas and laxative rectal solutions are classified in this group, regardless of mode of action.
Combined packages containing tablets and enemas are classified in this group.
Some 5th levels for plain substances also include combinations, e.g.:
A06AG10 - docusate sodium- and e.g. sorbitol or glycerol
A06AG11 - sodium lauryl sulfoacetate and e.g. sodium citrate
Sodium laurilsulfate is also classified in A06AG11.

The DDDs for enemas classified in this group are 1 enema.

A06AG10 - Docusate Sodium, incl. Combinations
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home